AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

NCT07094113 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

434

Enrollment

INDUSTRY

Sponsor class

Conditions

KRAS Altered Advanced or Metastatic Solid Tumors

Interventions

DRUG: AMG 410
DRUG: Pembrolizumab
DRUG: Panitumumab

Sponsor

Amgen